CNPR Certification Exam Study Guide Chapter 11
Clinical Trial Experimental - study in which the exposure status (e.g. assigned to active drug versus placebo) is determined by the investigator Randomized Controlled Trial - a special type of clinical trial in which assignment to an exposure is determined purely by chance Cohort Study - Observational study in which subjects with an exposure of interest (e.g. hypertension) and subjects without the exposure are identified and then followed forward in time to determine outcomes (e.g. stroke) Case Control Study - observational study that first identifies a group of subjects with a certain disease and a control group without the disease, and then looks to back in time (e.g. chart review) to find exposure to risk factors for the disease. This study is well suited for rare diseases Cross Sectional Study - Observational study that is done to examine presence or absence of a disease or presence or absence of an exposure at a particular time. Since exposure and outcome are ascertained at the same time, it is often unclear if the exposure preceded the outcome Case report or Case Series - Descriptive study that reports on a single or a series of patients with a certain disease. This type of study usually generates a hypothesis but cannot test a hypothesis because it does not include an appropriate comparison group Bias - any systemic error in the design or conduct of a study that results in a mistaken estimate of an exposures effect on risk or disease Selection Bias - bias introduced by the way in which participants are chosen for a study. For example, in a case control study using different criteria to select cases (e.g. sick, hospitalized population) versus controls (young, healthy outpatients) other than the presence of disease can lead the investigator to a false conclusion about an exposure Confounding - This occurs when an investigator falsely concludes that a particular exposure is causally related to a disease without adjusting for other factors that are known risk factors for the disease and are associated with the exposure Mean - equals the sum of observations divided by the number of observations Median - equals the observation in the center when all observations are ordered from smallest to largest; when there is an even number of observations the median is defined as the average of the middle two values Mode - equals the most frequently occurring value among all observations Percentile - equals the percentage of a distribution that is below a specific value. Interquartile Range - refers to the upper and lower boundary defining the middle 50% of observations. The upper boundary is the 75th percentile and the lower boundary is the 25th percentile Spread - (or variability) describes the manner in which data are scattered around a specific value (such as the mean) The most common measures are range, standard deviation and standard error of the mean Range - is the difference between the largest observation and the smallest Standard Deviation - measures the spread of data around the mean. One of this includes 68% of the values in a sample population and two include 95% of the values Standard Error of the Mean - describes the amount of variability in the measurement of the population mean from several different samples. This is in contrast to the standard deviation, which measures the variability of individual observations in a sample Incidence - the number of new events (e.g. death or a particular disease) that occur during a specified period of time in a population at risk for developing the events Incidence Rate - A term related to incidence that reports the number of new events that occur over the sum of time individuals in the population were at risk for having the event Prevalence - the number of persons in the population affected by a disease at a specific time divided by the number of persons in the population at the time Measures of Association - the types of measures used to define the association between exposures and outcome depends upon the type of data Relative Risk (risk ratio) - defined as the ratio of the incidence of disease in the exposed group divided by the corresponding incidence of disease in the unexposed group Odds ratio - is defined as the odds of exposure in the group with disease divided by the odds of exposure in the control group. It is often used to approximate the relative risk in case-control studies attributable risk or risk difference - is a measure of absolute risk. It represents the excess risk of disease in those exposed taking into account the background rate of disease. IT is defined as the difference between the incidence rates in the exposed and non-exposed groups Population Attributable Risk - is used to describe the excess rate of disease in the total study population of exposed and non-exposed individuals that is attributable to the exposure. This measure is calculated by multiplying the Attributable Risk by the proportion of exposed individuals in the population. NNT - The number needed to treat - It is the reciprocal of the absolute risk reduction absolute risk reduction - the absolute adverse event rate for placebos minus the absolute adverse event rate for treated patients Validity - refers to the extent to which a test or surrogate is measuring what we think it is measuring Sensitivity - is defined as the ability of the test to identify correctly those who have the disease. It is the number of subjects with a positive test who have disease divided by all subjects who have the disease. Specificity - is defined as the ability of the test to identify correctly those who do not have the disease positive predictive value - is the probability of disease in a patient with a positive test. A positive likelihood ratio - ratio that tells us the odds of disease if the test result is positive. LR+ = Sensitivity/(1- Specificity Negative likelihood ratio - ratio that tells us the odds of disease if the test result is negative LR- = (1-Sensitivity) / Specificity confidence interval - gives a range of values within which there is a high probability (95% by convention) that the true population value can be found Type I error (alpha) - type of error in hypothesis testing that is the probability of incorrectly concluding there is a statistically significant difference in the population when none exists Type II error (beta) - type of error in hypothesis testing that is the probability of incorrectly concluding that there is no statistically significant difference in a population where one exists Power - is a measure of the ability to detect a true difference. Kaplan-Meier analysis - measures the ratio of surviving subjects (or those without an event) divided by the total number of subjects at risk for the event. Every time a subject has an event, the ratio is recalculated. These ratios are then used to generate a curve to graphically depict the probability of survival
Información del documento
- Subido en
- 17 de abril de 2025
- Número de páginas
- 8
- Escrito en
- 2024/2025
- Tipo
- Examen
- Contiene
- Preguntas y respuestas